Archives
PP2A-Driven Autophagy and Drug Resistance in C. albicans Bio
2026-07-27
This study elucidates how protein phosphatase 2A (PP2A) regulates autophagy and enhances drug resistance in Candida albicans biofilms via ATG protein phosphorylation. The findings provide mechanistic insight into biofilm-associated antifungal resistance and highlight potential molecular targets for overcoming persistent fungal infections.
A Multimodal iPSC Platform Advances Cystic Fibrosis Drug Tes
2026-07-27
This study presents a robust induced pluripotent stem cell (iPSC) platform that enables disease modeling and drug testing for cystic fibrosis (CF), including rare CFTR variants. By combining 3D and planar airway epithelial assays, the research demonstrates genotype-specific functional differences and drug responses, advancing the field of personalized CF therapeutics.
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus: Practi
2026-07-26
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for high-yield synthesis of fluorescently labeled RNA probes for research applications such as in situ hybridization and Northern blotting. It is optimized for reproducibility and efficient Cy3 incorporation but should not be used for diagnostic or clinical workflows.
Carbenoxolone disodium: Technical Guide for 11β-HSD Inhibiti
2026-07-25
Carbenoxolone disodium is a well-characterized 11β-hydroxysteroid dehydrogenase inhibitor suitable for dissecting glucocorticoid signaling, gap junction communication, and corticosterone metabolism in tissue and cell-based research models. It is not recommended for in vivo efficacy studies or applications requiring rigorous off-target specificity.
ZK53 (BA8004): Reliable Human ClpP Activation for Translatio
2026-07-24
This article explores how ZK53 (SKU BA8004), a potent and selective human mitochondrial serine protease ClpP activator, solves real-world challenges in cell viability and cytotoxicity assays. Grounded in quantitative data and literature, we address protocol optimization, data reliability, and vendor selection—demonstrating why ZK53 is trusted for sensitive mitochondrial dysfunction modeling.
Sorafenib (BAY-43-9006) in Cancer Biology: Protocols & Innov
2026-07-24
Sorafenib (BAY-43-9006) sets the benchmark for multikinase inhibition in cancer biology, enabling precise control over tumor proliferation and angiogenesis in both in vitro and in vivo systems. Discover streamlined protocols, experimental insights, and troubleshooting tips that extract maximum value from this versatile cancer biology research tool.
Metformin Hydrochloride: Applied Protocols in Immunometaboli
2026-07-23
Metformin Hydrochloride (Metformin HCl) is revolutionizing immunometabolic research by enabling precise modulation of glucose and lipid pathways in both in vitro and in vivo immune assays. This article delivers actionable workflows, highlights the latest standardized protocols for whole-blood immune stimulation, and provides troubleshooting guidance to maximize reproducibility and biological insight.
Octenidine Dihydrochloride: Protocol Advances in Antiseptic
2026-07-23
Octenidine dihydrochloride stands out as a benchmark chemical antiseptic for laboratory research, offering robust, broad-spectrum activity and protocol flexibility. This article translates cutting-edge findings into practical workflows, troubleshooting guidance, and actionable tips for maximizing the utility of this high-purity antiseptic research compound.
Ziprasidone Hydrochloride: Advanced Mechanisms and Protocols
2026-07-22
Explore the multifaceted applications of Ziprasidone Hydrochloride in neuroscience and cancer metabolism research. This article delivers advanced analysis and protocol guidance, revealing mechanistic insights and workflow implications for Ziprasidone HCl in translational research.
8-Chloroadenosine: Precision Nucleoside Analog for RNA Studi
2026-07-22
8-Chloroadenosine is a high-purity nucleoside analog uniquely suited for dissecting RNA metabolism and transcriptional regulation in cancer research. Its robust inhibition of RNA synthesis and superior DMSO solubility make it indispensable for lncRNA functional studies and advanced molecular biology workflows.
Lyso-Tracker Red: Precision Lysosome Labeling in Live Cells
2026-07-21
Lyso-Tracker Red empowers researchers to unravel lysosomal dynamics in live cells with unmatched specificity, enabling intricate studies of autophagy, intracellular pathogens, and therapeutic mechanisms. This article details optimized workflows, advanced use-cases, and troubleshooting strategies for leveraging Lyso-Tracker Red in cutting-edge biomedical research.
BTK Inhibition in B-Cell Research: Translational Strategy Wi
2026-07-21
Explore how Ibrutinib (PCI-32765) enables precise B-cell receptor signaling inhibition, advances chronic lymphocytic leukemia research, and informs next-generation autoimmune disease models. This article offers mechanistic insights, protocol guidance, and strategic context for translational researchers, drawing on recent literature and APExBIO’s formulation expertise.
Expanding Symbiont Diversity in Xyleborus affinis Beetles
2026-07-20
This study identifies both novel and known fungal symbionts in Xyleborus affinis ambrosia beetles, revealing that ethanol-free isolation protocols significantly increase the diversity of fungi recovered from beetle mycangia and galleries. These findings refine experimental criteria for validating fungal mutualists and have broad implications for studying animal–fungus symbioses.
Improving In Vitro Evaluation of Cancer Drug Responses
2026-07-20
Schwartz’s dissertation advances how in vitro drug responses are evaluated by distinguishing proliferation arrest from cell death, providing a more nuanced understanding of anti-cancer efficacy. This approach offers practical implications for optimizing the assessment of agents like Axitinib (AG 013736) in preclinical research.
EZ Cap™ EPO mRNA: Advancing Erythropoiesis and Neurorepair W
2026-07-19
EZ Cap™ EPO mRNA (ψUTP) empowers researchers to achieve robust, immune-silent transgene expression for targeted erythropoiesis and neuroprotection studies. Its stability, Cap 1 structure, and pseudouridine modification enable high-yield EPO protein production, as evidenced in advanced spinal cord injury repair models.
740 records 14/50 page Previous Next First page 上5页 1112131415 下5页 Last page